Neuronetics Stock Investor Sentiment

STIM Stock  USD 3.66  0.17  4.44%   
About 55% of Neuronetics' investor base is interested to short. The analysis of overall sentiment of trading Neuronetics stock suggests that many investors are impartial at this time. Neuronetics' investing sentiment overview a quick insight into current market opportunities from investing in Neuronetics. Many technical investors use Neuronetics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.

Comfort Level 45

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Neuronetics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Neuronetics.

Neuronetics Historical Sentiment

Although Neuronetics' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Neuronetics, such as negative comments on social media and news outlets, may cause fear in the market and push Neuronetics' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Neuronetics.

Neuronetics Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Neuronetics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Neuronetics Historical Investor Sentiment

Investor biases related to Neuronetics' public news can be used to forecast risks associated with an investment in Neuronetics. The trend in average sentiment can be used to explain how an investor holding Neuronetics can time the market purely based on public headlines and social activities around Neuronetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Neuronetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Neuronetics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Neuronetics news discussions. The higher the estimate score, the more favorable the investor's outlook on Neuronetics.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of Neuronetics' Stock prices. Below is the latest headlines and news related to Neuronetics Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
There is far too much social signal, news, headlines, and media speculation about Neuronetics that are available to investors today. This information is accessible both publicly - through Neuronetics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuronetics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuronetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuronetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuronetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuronetics alpha.

Neuronetics Largest EPS Surprises

Earnings surprises can significantly impact Neuronetics' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-05-07
2024-03-31-0.31-0.270.0412 
2021-08-03
2021-06-30-0.24-0.29-0.0520 
2021-03-02
2020-12-31-0.24-0.190.0520 
2024-08-12
2024-06-30-0.27-0.33-0.0622 
2019-11-05
2019-09-30-0.43-0.370.0613 
2024-03-05
2023-12-31-0.26-0.190.0726 
View All Earnings Estimates
few days ago at gurufocus.com         
Neuronetics Names New CFO Ahead of Executive Transition STIM Stock News
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Neuronetics Appoints New Chief Financial Officer STIM Stock News
Gurufocus Stories at Macroaxis
few days ago at gurufocus.com         
Neuronetics Appoints New Chief Financial Officer
Gurufocus Stories at Macroaxis
few days ago at massdevice.com         
Neuronetics names Steven Pfanstiel chief financial officer
news
few days ago at massdevice.com         
Acquisition by Pfanstiel Steven of 200000 shares of Neuronetics subject to Rule 16b-3
news
over a week ago at finance.yahoo.com         
Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting
Yahoo News
over a week ago at news.google.com         
12 Best Performing NASDAQ Stocks According to Analysts - Insider Monkey
Google News at Macroaxis
over two weeks ago at thelincolnianonline.com         
Tradewinds LLC. Purchases 52,977 Shares of Neuronetics, Inc.
news
over two weeks ago at thelincolnianonline.com         
Neuronetics versus RxSight Head to Head Analysis
news
over a month ago at gurufocus.com         
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
Gurufocus Stories at Macroaxis
over a month ago at globenewswire.com         
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
Macroaxis News: globenewswire.com
over a month ago at gurufocus.com         
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635 STIM Stock News
Gurufocus Stories at Macroaxis
over a month ago at simplywall.st         
Insider Sellers Might Regret Selling Neuronetics Shares at a Lower Price Than Current Market Value
Simply Wall St News at Macroaxis
over a month ago at finance.yahoo.com         
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
Yahoo News
over a month ago at globenewswire.com         
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress...
Macroaxis News: globenewswire.com
There is far too much social signal, news, headlines, and media speculation about Neuronetics that are available to investors today. This information is accessible both publicly - through Neuronetics' media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Neuronetics-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Neuronetics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Neuronetics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Neuronetics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Neuronetics alpha.

Neuronetics Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Neuronetics Inc Q1 2025 Earnings Call Highlights Revenue Surge Amidst Margin Challenges
05/07/2025
2
Disposition of 193460 shares by Furlong Stephen of Neuronetics at 4.27 subject to Rule 16b-3
05/12/2025
3
Disposition of 6540 shares by Furlong Stephen of Neuronetics at 4.16 subject to Rule 16b-3
05/13/2025
4
Neuronetics, Inc. EVP Stephen Furlong Sells 193,460 Shares
05/15/2025
5
Acquisition by Muir Glenn P of 30000 shares of Neuronetics subject to Rule 16b-3
05/22/2025
6
Short Interest in Neuronetics, Inc. Decreases By 26.2
06/02/2025
7
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrooks Personalized Care Trial Program
06/10/2025
8
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635
06/20/2025
9
12 Best Performing NASDAQ Stocks According to Analysts - Insider Monkey
07/08/2025
10
Neuronetics Names New CFO Ahead of Executive Transition STIM Stock News
07/15/2025
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out Neuronetics Hype Analysis, Neuronetics Correlation and Neuronetics Performance.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.32)
Revenue Per Share
2.251
Quarterly Revenue Growth
0.836
Return On Assets
(0.19)
Return On Equity
(1.45)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.